Quick Asked: Finch Therapeutics Contact Us?
Last update: 05 May, 2024 
291 Views
Who is the ceo of finch therapeutics? Dr. Kassam is a Co-Founder and the Chief Medical Officer of Finch Therapeutics. Prior to co-founding Finch, Dr. Kassam was the Chief Medical Officer of OpenBiome, where as part of the founding team, he pioneered the application of the microbiome to treat disease. Dr.What are the earnings results for fundfinch therapeutics group fnch? Finch Therapeutics Group, Inc. (NASDAQ:FNCH) posted its earnings results on Tuesday, August, 10th. The company reported ($0.32) EPS for the quarter, missing the Thomson Reuters' consensus estimate of ($0.28) by $0.04.What is the upside for finch therapeutics group ftc stock? Their forecasts range from $25.00 to $34.00. On average, they expect Finch Therapeutics Group's stock price to reach $29.33 in the next year. This suggests a possible upside of 122.2% from the stock's current price. View analysts' price targets for Finch Therapeutics Group or view top-rated stocks among Wall Street analysts.What happened to finch therapeutics groups lock up period? Finch Therapeutics Group's lock-up period expired on Wednesday, September 15th. Finch Therapeutics Group had issued 7,500,000 shares in its public offering on March 19th. The total size of the offering was $127,500,000 based on an initial share price of $17.00.
Listing Results Finch Therapeutics Contact Us? Question Answers
Finch Therapeutics Information Finch Therapeutics Profile
Finch Therapeutics is unlocking the therapeutic potential of the microbiome through our human-first discovery platform. We use machine learning algorithms to reverse engineer successful fecal transplantations and other clinical datasets, identifying the microbes that drive responses in ...